class action lawsuit

Securities lawsuit against uniQure alleges misleading FDA disclosure statements about gene therapy candidate AMT-130. Stock fell 49% after November FDA feedback; investors must file claims by April 13, 2026.

REGENXBIO faces securities fraud lawsuit for allegedly making false statements about RGX-111 safety while withholding adverse trial data from investors between February 2022 and January 2026.

Nidec's stock plunges 22.7% after announcing accounting irregularities at its China unit. Class action litigation launched investigating potential securities law violations and shareholder damages.

UniQure faces class action lawsuit over alleged FDA disclosure misrepresentations. Investors have until April 13, 2026 deadline to join litigation.

Law firm investigates CoreWeave for allegedly concealing data center construction delays. Stock fell $14B after December disclosure of months-behind Texas facility project.

BellRing Brands faces securities fraud investigation for allegedly misrepresenting 2025 sales growth, attributing gains to retail inventory buildup rather than organic demand. Stock fell 33%.

Law firm sues uniQure for allegedly misrepresenting gene therapy trial status and FDA approval timeline, causing stock to surge 250% then fall 49% after FDA reversal.

REGENXBIO faces securities lawsuit for allegedly misleading investors about RGX-111 gene therapy safety concerns. FDA imposed clinical hold after trial participant developed CNS tumor.

Schall Law Firm launches securities fraud class action against Varonis Systems for allegedly making false statements about SaaS customer conversion and revenue growth during 2025.

Agilon Health faces securities class action lawsuit alleging materially false 2026 financial guidance and misleading statements about risk mitigation. Investors from February-August 2025 may participate.

Schall Law Firm recruits lead plaintiffs for MCTA securities fraud class action lawsuit stemming from alleged undisclosed promotion scheme and SEC trading suspension.

Class action lawsuit filed against Klarna alleging IPO securities fraud over undisclosed financial risks and misleading statements about loss reserves.

BlackRock TCP Capital faces securities fraud lawsuit alleging false statements about investment valuations and overstated net asset value. Investors have until April 6, 2026 to join.

Law firm seeks lead plaintiffs for MCTA class action lawsuit over alleged undisclosed stock promotion scheme and social media fraud. Deadline: February 17, 2026.

Klarna faces securities lawsuit alleging it concealed loss reserve increases in its September 2025 IPO. Investors have until February 20 to join the class action.

F5 faces class action lawsuit over undisclosed BIG-IP security breach. Stock plunged 10.9% after October disclosure; shareholders sought for litigation by February 17 deadline.

Rosen Law Firm filed a securities class action against Agilon Health for allegedly making false 2025 guidance statements. Investors harmed between February-August 2025 can participate; deadline March 2, 2026.

GSI Technology faces securities investigation for allegedly making false claims about chip capabilities. Stock dropped 14.2% after reports showed products didn't perform as advertised.

Class action lawsuit filed against Fermi Inc. alleging material misrepresentations in October 2025 IPO regarding Project Matador demand and financial viability disclosures.

Class action lawsuit filed against Ardent Health for allegedly overstating Q3 2025 revenue and inflating full-year EBITDA guidance by $57.5 million due to accounting system failures.